baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Call 160 CHKP 17.01.../ DE000GG8C568 /

2024-09-20 9:07:56 AM	Chg.-0.16	Bid10:00:26 PM	Ask10:00:26 PM	Underlying	Strike price	Expiration date	Option type
3.16EUR	-4.82%	- Bid Size: -	- Ask Size: -	Check Point Software...	160.00 USD	2025-01-17	Call

TeleTrader 09-10 Israeli army stops UN convoy for 8 hours, UNRWA says

GlobeNewswire 09-03 Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and E...

GlobeNewswire 08-30 Carahsoft Sponsors 15th Annual Billington Cybersecurity Summit in Washington, D.C. on September 3-6...

GlobeNewswire 08-29 Anaptys Announces Participation in September Investor Conferences

GlobeNewswire 08-28 Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Pro...

GlobeNewswire 08-28 BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire 08-27 Check Point Software to Acquire Cyberint to Transform Security Operations and Expand Managed Threat ...

TeleTrader 08-27 Ukrainian troops allegedly trying to enter Russia near Belgorod

GlobeNewswire 08-14 Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update

GlobeNewswire 08-14 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering

GlobeNewswire 08-13 Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire 08-13 Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma

GlobeNewswire 08-13 PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire 08-13 Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire 08-12 Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024...

GlobeNewswire 08-12 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...

GlobeNewswire 08-12 Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates

GlobeNewswire 08-08 ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 08-08 Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress

GlobeNewswire 08-08 PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting

GlobeNewswire 08-08 Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08-07 PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024

GlobeNewswire 08-06 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors

GlobeNewswire 08-06 Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire 08-06 BioXcel Therapeutics Reports Second Quarter 2024 Financial Results

Goldman Sachs Call 160 CHKP 17.01.../ DE000GG8C568 /

If you wish to receive reply to your feedback, please provide your email address.